Long-Term Safety, Tolerability, and Effectiveness of Lurasidone in Subjects With Schizophrenia or Schizoaffective Disorder: A Randomized, Active Comparator-Controlled Trial
Long-Term Safety, Tolerability, and Effectiveness of Lurasidone in Subjects With Schizophrenia or Schizoaffective Disorder: A Randomized, Active Comparator-Controlled Trial
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is safe and tolerable long term among clinically stable patients. The study will also assess the long term effectiveness of lurasidone as compared to an active comparator.
Main Inclusion Criteria:
To be eligible to enter the study, each patient must comply with the following inclusion criteria:
Main Exclusion Criteria:
To be excluded from entering this study if they fulfil any of the criteria below:
North Miami, Florida 33161, United States
Capital Federal, BUE C1425AHP, Argentina
Beer Yaakov, Beer Yaakov 70300, Israel
Natal, 3600, South Africa
Chulalongkorn University, Bangkok, Thailand
Klongsan, Bangkok, Thailand
Muang, Chiang Mai, Thailand